Elisa Zuffa

519 total citations
26 papers, 313 citations indexed

About

Elisa Zuffa is a scholar working on Hematology, Pulmonary and Respiratory Medicine and Genetics. According to data from OpenAlex, Elisa Zuffa has authored 26 papers receiving a total of 313 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Hematology, 9 papers in Pulmonary and Respiratory Medicine and 8 papers in Genetics. Recurrent topics in Elisa Zuffa's work include Chronic Myeloid Leukemia Treatments (10 papers), Acute Myeloid Leukemia Research (9 papers) and Pulmonary Hypertension Research and Treatments (9 papers). Elisa Zuffa is often cited by papers focused on Chronic Myeloid Leukemia Treatments (10 papers), Acute Myeloid Leukemia Research (9 papers) and Pulmonary Hypertension Research and Treatments (9 papers). Elisa Zuffa collaborates with scholars based in Italy and Canada. Elisa Zuffa's co-authors include S Tura, Nicola Vianelli, Giovanni Martinelli, Maria Concetta Petti, L Gugliotta, Carlo Finelli, Franco Mandelli, Umberto Magrini, Lorenzo Gianni and C Bernasconi and has published in prestigious journals such as Circulation, Blood and Journal of the American College of Cardiology.

In The Last Decade

Elisa Zuffa

24 papers receiving 306 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elisa Zuffa Italy 8 214 212 106 92 29 26 313
Cristina Bucelli Italy 9 162 0.8× 173 0.8× 81 0.8× 73 0.8× 8 0.3× 33 250
Sabrina Caberlon Italy 8 264 1.2× 218 1.0× 156 1.5× 110 1.2× 6 0.2× 12 349
Rangit Vallapureddy United States 10 352 1.6× 313 1.5× 219 2.1× 102 1.1× 11 0.4× 16 446
Federico Vozella Italy 10 81 0.4× 162 0.8× 82 0.8× 46 0.5× 13 0.4× 31 241
Meira Zoldan Israel 8 116 0.5× 154 0.7× 53 0.5× 31 0.3× 80 2.8× 9 306
María Soledad Undurraga Chile 4 361 1.7× 425 2.0× 36 0.3× 212 2.3× 19 0.7× 9 460
Juan Julio Kassack Ipiña Mexico 4 366 1.7× 418 2.0× 41 0.4× 210 2.3× 20 0.7× 5 471
Meera Yogarajah United States 6 156 0.7× 168 0.8× 84 0.8× 56 0.6× 5 0.2× 17 230
Amir T. Fathi United States 7 95 0.4× 175 0.8× 73 0.7× 20 0.2× 9 0.3× 24 233
Shanti Amé France 8 115 0.5× 168 0.8× 32 0.3× 53 0.6× 4 0.1× 17 207

Countries citing papers authored by Elisa Zuffa

Since Specialization
Citations

This map shows the geographic impact of Elisa Zuffa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elisa Zuffa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elisa Zuffa more than expected).

Fields of papers citing papers by Elisa Zuffa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elisa Zuffa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elisa Zuffa. The network helps show where Elisa Zuffa may publish in the future.

Co-authorship network of co-authors of Elisa Zuffa

This figure shows the co-authorship network connecting the top 25 collaborators of Elisa Zuffa. A scholar is included among the top collaborators of Elisa Zuffa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elisa Zuffa. Elisa Zuffa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rondoni, Michela, Giovanni Marconi, Annalisa Nicoletti, et al.. (2025). Low WT1 Expression Identifies a Subset of Acute Myeloid Leukemia with a Distinct Genotype. Cancers. 17(7). 1213–1213.
2.
Dardi, Fabio, Alessandra Manes, Elisa Zuffa, et al.. (2021). A pragmatic approach to risk assessment in pulmonary arterial hypertension using the 2015 European Society of Cardiology/European Respiratory Society guidelines. Open Heart. 8(2). e001725–e001725. 9 indexed citations
3.
Fiorini, Giulia, et al.. (2021). Anagrelide Treatment and Congestive Heart Failure in the COVID-19 Era: A Case Report. 11(6). 1–3. 1 indexed citations
4.
Dardi, Fabio, Massimiliano Palazzini, Enrico Gotti, et al.. (2019). Abstract 9570: Prognostic Value of Stroke Volume Index in Patients With Pulmonary Arterial Hypertension at Intermediate Risk. Circulation. 1 indexed citations
5.
Dardi, Fabio, Alessandra Manes, Massimiliano Palazzini, et al.. (2019). ADDITIONAL ROLE OF UNMODIFIABLE RISK FACTORS IN PULMONARY ARTERIAL HYPERTENSION RISK STRATIFICATION ACCORDING TO CURRENT ESC/ERS GUIDELINES. Journal of the American College of Cardiology. 73(9). 1913–1913. 1 indexed citations
6.
Dardi, Fabio, Massimiliano Palazzini, Elisa Zuffa, et al.. (2019). P4680Prognostic value of stroke volume index in patients with pulmonary arterial hypertension at intermediate risk. European Heart Journal. 40(Supplement_1). 2 indexed citations
7.
Rinaldi, Andrea, Fabio Dardi, Enrico Monti, et al.. (2018). P6341Haemodynamic and exercise effects of different types of initial oral combination therapy in pulmonary arterial hypertension. European Heart Journal. 39(suppl_1). 5 indexed citations
8.
Dardi, Fabio, Massimiliano Palazzini, Andrea Rinaldi, et al.. (2018). P4538Simplified table for risk stratification in patients with different types of pulmonary arterial hypertension. European Heart Journal. 39(suppl_1). 3 indexed citations
9.
Polverelli, Nicola, Giovanni Martinelli, Lucia Catani, et al.. (2017). The relevance of a low JAK2V617F allele burden in clinical practice: a monocentric study. Oncotarget. 8(23). 37239–37249. 18 indexed citations
10.
Baldazzi, Carmen, Simona Luatti, Elisa Zuffa, et al.. (2016). Complex chromosomal rearrangements leading to MECOM overexpression are recurrent in myeloid malignancies with various 3q abnormalities. Genes Chromosomes and Cancer. 55(4). 375–388. 5 indexed citations
11.
Mancini, Manuela, Nevena Veljković, Valentina Corradi, et al.. (2009). 14‐3‐3 Ligand Prevents Nuclear Import of c‐ABL Protein in Chronic Myeloid Leukemia. Traffic. 10(6). 637–647. 30 indexed citations
12.
Zuffa, Elisa, Manuela Mancini, Eleonora Pagnotta, et al.. (2008). P53 oncosuppressor influences selection of genomic imbalances in response to ionizing radiations in human osteosarcoma cell line SAOS-2. International Journal of Radiation Biology. 84(7). 591–601. 6 indexed citations
13.
Bandini, Giuseppe, Elisa Zuffa, G. Rosti, et al.. (2008). Long-term outcome of adults with acute myelogenous leukaemia: results of a prospective, randomized study of chemotherapy with a minimal follow-up of 7 years. British Journal of Haematology. 77(4). 486–490. 3 indexed citations
14.
Zuffa, Elisa, Claudia Maria Hattinger, Massimo Serra, et al.. (2007). Genomic imbalances associated with secondary acute leukemias in Hodgkin lymphoma. Oncology Reports. 18(6). 1427–34. 7 indexed citations
15.
Mancini, Manuela, Elisa Zuffa, Giovanni Martinelli, et al.. (2006). Persistent Cdk2 inactivation drives growth arrest of BCR-ABL-expressing cells in response to dual inhibitor of SRC and ABL kinases SKI606. Leukemia Research. 31(7). 979–987. 22 indexed citations
16.
Mancini, Manuela, et al.. (2005). Tyrosine Kinase Inhibitor STI571 (Imatinib) Cooperates with Wild-Type p53 on K562 Cell Line to Enhance Its Proapoptotic Effects. Acta Haematologica. 114(3). 150–154. 4 indexed citations
17.
Tura, S, Domenico Russo, Elisa Zuffa, et al.. (1992). A prospective comparison of α-IFN and conventional chemotherapy in Ph+ chronic myeloid leukemia. Clinical and cytogenetic results at 2 years in 322 patients. Haematologica. 77(3). 204–214. 15 indexed citations
18.
Zaccaria, Alfonso, Giovanni Martinelli, Marina Buzzi, et al.. (1992). M-BCR breakpoint location does not predict survival in Philadelphia chromosome-positive chronic myeloid leukemia.. PubMed. 77(1). 16–20. 8 indexed citations
19.
Visani, Giuseppe, Carlo Finelli, Maria Concetta Petti, et al.. (1990). Myelofibrosis with myeloid metaplasia: clinical and haematological parameters predicting survival in a series of 133 patients. British Journal of Haematology. 75(1). 4–9. 145 indexed citations
20.
Zuffa, Elisa, Renato Fanin, Nicoletta Testoni, et al.. (1989). Low-dose interferon-alpha in Ph+ chronic myeloid leukemia: clinical cytogenetic and cell culture study.. PubMed. 73(6). 499–502. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Cristina Bucelli Breakdown of academic impact, for papers by Sabrina Caberlon Breakdown of academic impact, for papers by Rangit Vallapureddy Breakdown of academic impact, for papers by Federico Vozella Breakdown of academic impact, for papers by Meira Zoldan Breakdown of academic impact, for papers by María Soledad Undurraga Breakdown of academic impact, for papers by Juan Julio Kassack Ipiña Breakdown of academic impact, for papers by Meera Yogarajah Breakdown of academic impact, for papers by Amir T. Fathi Breakdown of academic impact, for papers by Shanti Amé
Rankless by CCL
2026